Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Irina Fedyakina"'
Autor:
Sergei Onikienko, Maxim Vinokurov, Marina Yurinskaya, Alexander Zemlyanoi, Sergei Abkin, Elvira Shaykhutdinova, Victor Palikov, Alexander Ivanov, Olga Smirnova, Irina Fedyakina, Natalia Bychkova, Olga Zatsepina, David Garbuz, Michael Evgen’ev
Publikováno v:
Biomedicines, Vol 10, Iss 9, p 2155 (2022)
The ongoing epidemic caused by SARS-CoV-2 infection led to the search for fundamentally new ways and means to combat inflammation and other pathologies caused by this virus. Using a cellular model of lipopolysaccharide (LPS)-induced sepsis (human pro
Externí odkaz:
https://doaj.org/article/adc22318c17c4cafbf5f299a4212223a
Autor:
Amir Tukhvatulin, Alina Dzharullaeva, Alina Erokhova, Anastasia Zemskaya, Maxim Balyasin, Tatiana Ozharovskaia, Olga Zubkova, Natalia Shevlyagina, Vladimir Zhukhovitsky, Irina Fedyakina, Ivan Pruss, Dmitry Shcheblyakov, Boris Naroditsky, Denis Logunov, Alexander Gintsburg
Publikováno v:
Vaccines, Vol 8, Iss 3, p 519 (2020)
Along with their excellent safety profiles, subunit vaccines are typically characterized by much weaker immunogenicity and protection efficacy compared to whole-pathogen vaccines. Here, we present an approach aimed at bridging this disadvantage that
Externí odkaz:
https://doaj.org/article/32dd6ef55add4500b9afc5bd69399b33
Autor:
Elena Matyugina, Ivan Petushkov, Sergei Surzhikov, Vasily Kezin, Anna Maslova, Olga Ivanova, Olga Smirnova, Ilya Kirillov, Irina Fedyakina, Andrey Kulbachinskiy, Sergey Kochetkov, Anastasia Khandazhinskaya
Publikováno v:
International Journal of Molecular Sciences
Volume 24
Issue 4
Pages: 3361
Volume 24
Issue 4
Pages: 3361
The SARS-CoV-2 betacoronavirus pandemic has claimed more than 6.5 million lives and, despite the development and use of COVID-19 vaccines, remains a major global public health problem. The development of specific drugs for the treatment of this disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac9aebe471842bd6d06df8cd9000d3a0
https://doi.org/10.3390/ijms24043361
https://doi.org/10.3390/ijms24043361
Autor:
A. I. Tukhvatulin, Alina S. Erokhova, Natalia V. Shevlyagina, Alina S. Dzharullaeva, Anastasia Zemskaya, Olga V. Zubkova, Alexander L. Gintsburg, Dmitry V. Shcheblyakov, Denis Y. Logunov, Vladimir G. Zhukhovitsky, T A Ozharovskaia, Irina Fedyakina, Maxim Balyasin, Ivan Pruss, Boris S. Naroditsky
Publikováno v:
Vaccines
Volume 8
Issue 3
Vaccines, Vol 8, Iss 519, p 519 (2020)
Volume 8
Issue 3
Vaccines, Vol 8, Iss 519, p 519 (2020)
Along with their excellent safety profiles, subunit vaccines are typically characterized by much weaker immunogenicity and protection efficacy compared to whole-pathogen vaccines. Here, we present an approach aimed at bridging this disadvantage that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03be338e8cd93bfaab4c771cd5c510d2